Combined use of PDE5 inhibitors and nitrates in the treatment of pulmonary arterial hypertension in patients with heart failure.
Stehlik, Josef
Combined use of PDE5 inhibitors and nitrates in the treatment of pulmonary arterial hypertension in patients with heart failure. [electronic resource] - Journal of cardiac failure Feb 2009 - 31-4 p. digital
Publication Type: Case Reports; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
1532-8414
10.1016/j.cardfail.2008.09.005 doi
Cyclic GMP
Drug Therapy, Combination
Heart Failure--complications
Humans
Hypertension, Pulmonary--complications
Isosorbide Dinitrate--therapeutic use
Male
Middle Aged
Nitro Compounds--therapeutic use
Nitroglycerin--therapeutic use
Phosphodiesterase 5 Inhibitors
Phosphodiesterase Inhibitors--therapeutic use
Piperazines--therapeutic use
Pulmonary Artery--drug effects
Purines--therapeutic use
Sildenafil Citrate
Sulfones--therapeutic use
Vasodilation--drug effects
Vasodilator Agents--therapeutic use
Combined use of PDE5 inhibitors and nitrates in the treatment of pulmonary arterial hypertension in patients with heart failure. [electronic resource] - Journal of cardiac failure Feb 2009 - 31-4 p. digital
Publication Type: Case Reports; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
1532-8414
10.1016/j.cardfail.2008.09.005 doi
Cyclic GMP
Drug Therapy, Combination
Heart Failure--complications
Humans
Hypertension, Pulmonary--complications
Isosorbide Dinitrate--therapeutic use
Male
Middle Aged
Nitro Compounds--therapeutic use
Nitroglycerin--therapeutic use
Phosphodiesterase 5 Inhibitors
Phosphodiesterase Inhibitors--therapeutic use
Piperazines--therapeutic use
Pulmonary Artery--drug effects
Purines--therapeutic use
Sildenafil Citrate
Sulfones--therapeutic use
Vasodilation--drug effects
Vasodilator Agents--therapeutic use